Professor Claire Vajdic/sites/default/files/2024-03/Claire-Vajdic.png2024/07/23 13:00:00
HPV vaccination is more than 99 percent effective at preventing cervical cancer and, in Australia, is available from adolescence to 25 years of age. In some communities, however, persistent barriers to HPV vaccination remain.
Professor Claire Vajdic is part of a Kirby Institute team working on INCLUDE: a suresearch project that aims to identify and address barriers to cervical cancer prevention in primary care. In this webinar, Claire will present new national datasets that identify gaps in HPV vaccination for key population groups, and talk about the new health equity digital navigation tool that is being co-designed for use by the public, clinicians and government.
